Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins and Reed Abelson

in

Clinical Trials, CVS Caremark Corporation, Drugs (Pharmaceuticals), Eli Lilly and Company, GLP-1 RAs (Drug), Health Insurance and Managed Care, Novo Nordisk A/S, Obesity, Prices (Fares, Fees and Rates), Research
←Transportation Secretary Gets Pressed Over Repeated Airport Failures And Musk’s FAA Cuts
Johnny Rodriguez, Country Music Star, Dead at 73→

More posts

  • Bessent compares tech outages to vaccines

  • West Coast bracing for more coastal flooding as Thanksgiving travel week begins

  • Yoro sees red as Ngumoha shines – Liverpool v Man Utd player ratings

  • Billy Ray Cyrus’ Ex-Wife Firerose Resurfaces Past Abuse Claims Day After Miley’s Wedding

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube